Latest Morning Briefing Stories
COVID Vaccine Trials Move at Warp Speed, But Recruiting Black Volunteers Takes Time
The National Institutes of Health has suggested minorities should be overrepresented in COVID-19 vaccine trials — perhaps at rates that are double their percentage of the U.S. population. But efforts to recruit patients from racial minority groups are just beginning, while some trials have already advanced to phase 3.
COVID Exodus Fills Vacation Towns With New Medical Pressures
As people leave COVID-stricken cities to settle semi-permanently in vacation communities, locals assess how these new residents are changing demands on medical services.
New Dental Treatment Helps Fill Cavities and Insurance Gaps for Seniors
A new treatment for tooth decay is cheaper, quicker and less painful than getting a filling. Originally touted as a solution for kids, silver diamine fluoride is poised to become a game changer for treating cavities in older adults or those with disabilities that make oral care difficult.
Tough to Tell COVID From Smoke Inhalation Symptoms — And Flu Season’s Coming
Respiratory symptoms stemming from coronavirus infection and smoke inhalation are too similar to distinguish without a full workup. This is complicating the jobs of health care workers as wildfires rage up and down the West Coast.
Es difícil decir si es COVID, síntomas por inhalar humo… o la gripe que ya llega
Por los incendios en California, pacientes llegan a los centros de salud con síntomas similares a los de COVID. Y hay que seguir los protocolos.
NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial
The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.
‘It Seems Systematic’: Doctors Cite 115 Cases of Head Injuries From Crowd Control Devices
In the most comprehensive tally of such injuries to date, the Physicians for Human Rights scoured publicly available data — including social media, news accounts and lawsuits — to document and name victims of summer protests. Still, the group cautions, it’s likely an undercount.
Los NIH, “muy preocupados” por efectos secundarios en ensayo de vacuna para COVID
La Administración de Alimentos y Medicamentos está evaluando la posibilidad de seguir a los reguladores británicos y reanudar el ensayo de la vacuna. Pero hay dudas.
Readers and Tweeters Grapple With COVID Therapies and Forecasts
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Making Gyms Safer: Why the Virus Is Less Likely to Spread There Than in a Bar
Gyms are reopening with fewer people and more protocols, and they want to rehabilitate their pandemic-battered image. Although there’s not much evidence, they say science is on their side.